WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) announced today that it has entered into a memorandum of understanding (MOU) with the the Association of British HealthTech Industries (ABHI) to facilitate collaboration between the two organizations.
WASHINGTON, D.C. – As part of the medical technology industry’s multi-front battle to combat the coronavirus (COVID-19) pandemic, today the Advanced Medical Technology Association (AdvaMed) announced the launch of a new platform (www.VentConnect.org) to connect ventilator companies with component suppliers to help quickly scale production and distribution of these vital devices.
WASHINGTON, D.C. – The Advanced Medical Association (AdvaMed) requested the United States Trade Representative (USTR) provide additional tariff exclusions for medical devices, components and supplies coming from China needed in the fight against the coronavirus (COVID-19) pandemic.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) has joined with several groups representing medical professionals, advocacy groups, international societies and the health care industry to form The Global Coalition for Radiotherapy (TGCR) to ensure cancer patients have access to this vital therapy during the COVID-19 pandemic and beyond.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today thanked Congress and the President for working together to pass the latest COVID-19 stimulus package, which will provide additional relief for smaller medical technology companies and a significant boost to the nation’s testing capabilities.
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement:
WASHINGTON, D.C. – Several prominent medical technology company executives have been named to the White House task force designated by President Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus (COVID-19) pandemic.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released the following statement from President and CEO Scott Whitaker on STERIS’s Emergency Use Authorization (EUA) from FDA for certain V-PRO® Low Temperature Sterilization Systems to allow health care providers to decontaminate N95 respirators on site:
WASHINGTON – New clinical evidence produced in recent weeks has shown the benefits of non-invasive ventilators for use in less severe cases of COVID-19-related respiratory problems, which constitute the majority of cases nationwide. In a series of white papers, published evidence, and case studies from both China and Italy, experts say many coronavirus patients with less-severe respiratory distress could benefit from non-invasive ventilation therapy, thus freeing more invasive ventilation devices for the most critically ill patients nationwide.
WASHINGTON, D.C. – An editorial authored by Andrew Fish, Chief Strategy Officer for The Advanced Medical Technology Association (AdvaMed), appeared this week in Real Clear Health on the benefits of telehealth in connecting patients and health care providers, particularly during the current coronavirus (COVID-19) health care crisis.